Skip to main content
MDLZ
NASDAQ Manufacturing

Mondelez Reports Mixed Q1 Results: Adjusted EPS Down, Cash Flow Declines, Outlook Reaffirmed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Neutral
Importance info
8
Price
$60.22
Mkt Cap
$75.134B
52W Low
$51.201
52W High
$71.15
52W Position info
18% above low
Off High info
15% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

MDLZ sits 18% above its 52-week low of $51.201.

Summary

Mondelez International reported mixed first-quarter 2026 results, with GAAP diluted EPS increasing but adjusted EPS declining 14.9% on a constant currency basis, alongside a significant drop in operating cash flow and free cash flow.


Key Events · Earnings and Guidance · MDLZ

  • Q1 Financial Performance

    Net revenues increased 8.2% to $10.08 billion, with organic net revenue growth of 3.0%. GAAP diluted EPS rose 41.9% to $0.44, but adjusted EPS decreased 14.9% on a constant currency basis to $0.67.

  • Cash Flow and Capital Allocation

    Cash provided by operating activities significantly declined to $0.5 billion from $1.092 billion in Q1 2025. Free cash flow also dropped to $0.2 billion from $0.815 billion in the prior year. The company reported no common stock repurchases in Q1 2026, a halt from $1.522 billion in Q1 2025.

  • Full-Year Outlook Reaffirmed

    Mondelez International reaffirmed its 2026 outlook, expecting organic net revenue growth in the range of flat to 2% and adjusted EPS growth of flat to 5% on a constant currency basis. Free cash flow is still projected at approximately $3 billion.


Analysis · MDLZ · Manufacturing

Mondelez International's first-quarter results present a mixed picture for investors. While GAAP diluted EPS increased significantly and organic net revenue grew, adjusted EPS declined by nearly 15% on a constant currency basis. More critically, both operating cash flow and free cash flow saw substantial year-over-year decreases, and the company halted share repurchases for the quarter. The reaffirmation of the full-year outlook provides some stability but the underlying operational and cash flow trends, coupled with the pause in capital returns, suggest potential headwinds despite top-line growth.

At the time of this filing, MDLZ was trading at $60.22 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $75.1B. The 52-week trading range was $51.20 to $71.15. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MDLZ - Latest Insights

MDLZ
Jun 18, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $60.26
Real-time Price: $60.78 info
Change: +$0.520 (+0.86%) info
Market Cap: $77.879B info
MDLZ
May 13, 2026, 7:44 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $61.57
Real-time Price: $60.78 info
Change: -$0.790 (-1%) info
Market Cap: $77.879B info
MDLZ
Apr 28, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $59.76
Real-time Price: $60.78 info
Change: +$1.02 (+2%) info
Market Cap: $77.879B info
MDLZ
Apr 28, 2026, 4:05 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $59.35
Real-time Price: $60.78 info
Change: +$1.43 (+2%) info
Market Cap: $77.879B info
MDLZ
Feb 04, 2026, 12:39 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $59.45
Real-time Price: $60.78 info
Change: +$1.33 (+2%) info
Market Cap: $77.879B info